Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Cannabis medicine 'causes harm'

BBC Online

Friday 01 Apr 2005

---

Cannabis-based medicines can cause paranoia and anxiety in some people, a
study has suggested.

Swiss researchers found two out of eight men given drugs containing THC, a
chemical extracted from cannabis, developed psychotic effects.

The University of Lausanne team said the public needed to be aware cannabis
medicine could have such side effects.

The possibility of using THC to treat multiple sclerosis and pain relief is
currently being explored.

GW Pharmaceuticals, the firm granted a UK licence to develop cannabis-based
drugs, said: "The levels of THC used in this study would not be used in our
medicines.

"We, and everyone else in this field, are aware that THC can lead to
psychosis."

'Great impact'

During the study, one man reacted to dronabinol, which is licensed for
medical use in the US as it is a synthetic, and another to a liquid form of
natural THC, the journal BMC Psychiatry reported.

Within hours of taking the drugs orally, both men started displaying
psychotic symptoms. Neither had a history of psychiatric problems.

Report author Dr Bernard Favrat said the findings were surprising as the
doses used were relatively mild.

"We were not expecting these results. The drugs had a great impact on the
people and we have to recognise that drugs which are developed using THC
have this risk.

"I am not saying we should not develop them, but just that we need to
proceed with caution."

Young people

Other recent studies have linked the use of cannabis to mental health problems.

A study by New Zealand scientists, published in March, suggested smoking
cannabis virtually doubled the risk of developing mental illnesses such as
schizophrenia.

And in December US researchers warned young people that using cannabis led
to an increased risk of psychosis later in life.

An MS drug containing 50% THC, which is being developed by GW
Pharmaceuticals, is expected to come before regulators later this year. The
firm is also developing other drugs containing THC for cancer and back pain.

A spokesman for the firm said the drugs would also contain agents which
modify the effects of THC.

The charity DrugScope said that it did not want to see any cannabis-based
medicines banned simply because of fears that they may produce side effects.

"There is strong evidence that cannabis can help to treat a range of
conditions, and if they can we are in favour of them," it said.

 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!